Pinto-Souza Caroline Cristina, Kaihara Julyane Natsumi Saito, Rossini Bruno César, Cavalli Ricardo de Carvalho, Dos Santos Lucilene Delazari, Sandrim Valéria Cristina
Universidade Estadual Paulista Instituto de Biociências de Botucatu Departamento de Biofísica e Farmacologia BotucatuSP Brasil Departamento de Biofísica e Farmacologia, Instituto de Biociências de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brasil.
Universidade Estadual Paulista Faculdade de Ciências Agronômicas Departamento de Biotecnologia e Bioprocessos São Paulo Brasil Departamento de Biotecnologia e Bioprocessos, Faculdade de Ciências Agronômicas, Universidade Estadual Paulista, Botucatu, São Paulo, Brasil.
Rev Bras Ginecol Obstet. 2025 Jul 15;47. doi: 10.61622/rbgo/2025rbgo54. eCollection 2025.
This study aims to compare the plasma protein profiles between 7 preeclampsia patients with severe features (PE+) and 7 preeclampsia patients without severe features (PE-) and 10 healthy pregnancies (HP); identify differentially expressed proteins among these groups and explore the altered signaling pathways and their association with the severity of this cardiovascular condition.
Plasma proteins were quantified using mass spectrometry, followed by comprehensive bioinformatics and statistical analyses. Protein identification and annotation were performed using UniProt and PatternLab for Proteomics. Multivariate statistical analyses, including PLS-DA and sPLS-DA, as well as VIP score evaluation and Volcano plot visualization, were conducted with MetaboAnalyst to assess group separation and identify key discriminative features. Functional enrichment and pathway analyses were carried out using Metascape.
Using a fold change and volcano plot validation of 1.2, comparisons between HP and PE+ revealed that proteins such as AMBP (inter-alpha trypsin inhibitor light chain), VTN (vitronectin), CLU (clusterin), F2 (prothrombin), and PZP (pregnancy zone protein) were upregulated in PE+. Conversely, ITIH4 (inter-alpha trypsin inhibitor heavy chain H4), APOL1 (apolipoprotein 1) and SERPIND1 (heparin cofactor II) were downregulated in PE+ relative to HP. When comparing HP with PE-, SERPINA3 (alpha-1-antichymotrypsin) and HBB (hemoglobin subunit beta) were downregulated in PE-. Between PE- and PE+, APCS (serum amyloid P component) and HBB were upregulated in PE+; whereas SERPINC1 (antithrombin), PSG1 (pregnancy-specific beta-1-glycoprotein 1), ITIH4, and C5 (complement C5) were downregulated in PE+ compared to PE-.
These findings offer valuable insights into the different pathophysiological mechanisms underlying the two subgroups of PE. The upregulated proteins in PE+ (AMBP, VTN, CLU, F2, PZP, APCS, and HBB) play key roles in regulating blood pressure, modulating the extracellular matrix and influencing immune responses. Overall, this research deepens our understanding of the complexity and clinical significance of PE.
本研究旨在比较7例重度子痫前期患者(PE+)、7例非重度子痫前期患者(PE-)和10例正常妊娠(HP)的血浆蛋白质谱;确定这些组之间差异表达的蛋白质,探索信号通路的改变及其与这种心血管疾病严重程度的关联。
采用质谱法定量血浆蛋白质,随后进行全面的生物信息学和统计分析。使用UniProt和蛋白质组学PatternLab进行蛋白质鉴定和注释。使用MetaboAnalyst进行多变量统计分析,包括偏最小二乘判别分析(PLS-DA)和稀疏偏最小二乘判别分析(sPLS-DA),以及变量重要性投影(VIP)评分评估和火山图可视化,以评估组间分离并识别关键判别特征。使用Metascape进行功能富集和通路分析。
通过1.2倍变化和火山图验证,HP与PE+比较显示,如AMBP(α-间胰蛋白酶抑制剂轻链)、VTN(玻连蛋白)、CLU(簇集素)、F2(凝血酶原)和PZP(妊娠区蛋白)等蛋白质在PE+中上调。相反,相对于HP,ITIH4(α-间胰蛋白酶抑制剂重链H4)、APOL1(载脂蛋白1)和SERPIND1(肝素辅因子II)在PE+中下调。当比较HP与PE-时,SERPINA3(α-1-抗糜蛋白酶)和HBB(血红蛋白亚基β)在PE-中下调。在PE-和PE+之间,APCS(血清淀粉样蛋白P成分)和HBB在PE+中上调;而与PE-相比,SERPINC1(抗凝血酶)、PSG1(妊娠特异性β-1-糖蛋白1)、ITIH4和C5(补体C5)在PE+中下调。
这些发现为PE两个亚组不同的病理生理机制提供了有价值的见解。PE+中上调的蛋白质(AMBP、VTN、CLU、F2、PZP、APCS和HBB)在调节血压、调节细胞外基质和影响免疫反应中起关键作用。总体而言,本研究加深了我们对PE复杂性和临床意义的理解。